BridgeMD
New treatment option for Caregiver
Official title mHealth for Early Psychosis Caregivers in Statewide Program Outreach
ClinicalTrials.gov ID: NCT07225179
What this study is testing
- What it's testing
- The purpose of this study is to pilot the delivery of an mHealth intervention for caregivers to young people with early psychosis within a network of early psychosis intervention programs in the state of North Carolina. The investigators will examine the feasibility of recruitment through program outreach, develop North Carolina specific outreach resources to be used with the mHealth intervention and evaluate the effectiveness of this intervention for reducing caregiver psychological morbidity and improving family communication.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years or older
- North Carolina resident
- Caregiver to a young adult with early psychosis, wherein early psychosis is defined as: (1) Being between the ages of 15 and 30, and (2) Within the...
- A positive screen according to the Caregiver Prime Screen - Revised (endorsed two or more responses of five or six ("somewhat"/"definitely" agree)
- Own an Apple iPhone
You likely can't join if
- Participant failed to demonstrate understanding of study details in comprehension screening process.
- Previous enrollment in a study involving Bolster.
- Activity on screening questionnaires that indicates suspicious or dishonest participation such that the participant is likely to be a "malicious...
See the full eligibility criteria
- 18 years or older
- North Carolina resident
- Caregiver to a young adult with early psychosis, wherein early psychosis is defined as: (1) Being between the ages of 15 and 30, and (2) Within the past five years, the young adult first experienced hallmark symptoms...
- A positive screen according to the Caregiver Prime Screen - Revised (endorsed two or more responses of five or six ("somewhat"/"definitely" agree)
- Own an Apple iPhone
- Have access to the internet (e.g., via WiFi or data plan)
- Self-identify as a caregiver of the affected person
- Are proficient in English to the degree necessary to complete study assessments and engage meaningfully in the intervention
- Participant failed to demonstrate understanding of study details in comprehension screening process.
- Previous enrollment in a study involving Bolster.
- Activity on screening questionnaires that indicates suspicious or dishonest participation such that the participant is likely to be a "malicious actor" or "gamer" (i.e. an individual that attempts to enroll in online...
The study team makes the final eligibility decision.
Where it's taking place
- Chapel Hill, North Carolina, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chapel Hill, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.